Weekly Funding Opportunities

[Med Research]

REMINDER: Toffler Scholar Program applications are due MONDAY, NOVEMBER 9, 2020.
Toffler Scholar Program<https://med.fsu.edu/researchdivision/toffler-scholar-program>
Open to FSU researchers. The Toffler Scholar Program was created by the Trustees of the Karen Toffler Charitable Trust, a 501 C3 nonprofit foundation focused on early-stage research that advances the medical field in profound, high-impact ways. Tapping into the deep legacy of their founders, best-selling authors and futurists, Alvin and Heidi Toffler, the trust exists to be a catalyst for future – focused breakthroughs. The Toffler Scholar Program focuses on helping university medical researchers gain access to support, and a network for often underfunded innovations. It is a nimble source of financial support for medical researchers working on early-stage, future-focused brain science.  Together with the FSU College of Medicine, the program helps foster new ways of thinking and problem solving to find solutions to humanity’s most difficult problems. Toffler Scholar grants are one-year grants that currently range from $20,000 - $30,000 per award.
Due November 9, 2020. Med-RA draft review is not required.

Desmoid Tumor Research<https://urldefense.com/v3/__https://dtrf.org/wp-content/uploads/2020/03/Dec-2020-General-RFP.pdf__;!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmNK6d6o0$ >
The Desmoid Tumor Research Foundation welcomes applications for its research grant program. Through the program, grants of up to $65,000 will be awarded for research that advances current scientific knowledge of desmoid tumors using science and creative clinical applications, as well as novel approaches that addresses potential leads based on prior research. Proposals with additional sources of funding support are particularly desirable, and researchers must be willing to collaborate with other scientists and institutions with similar interests. Grantees must agree to participate as reviewers in DTRF’s future grant review cycle and present the results of their research at the annual September International DTRF Desmoid Tumor Research Workshop.
Due December 1, 2020. Med-RA deadline to receive draft documents: November 16 (due to Thanksgiving break).

American Lung Association: Innovation Awards<https://urldefense.com/v3/__https://www.lung.org/getmedia/86b126cf-2311-4c5e-9bbe-8996c246c03f/2021-innovation-award-rfp-and-app-guide.pdf__;!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmXlIxSmo$ >
The American Lung Association works to fight lung disease by advancing treatment and unlocking the secrets of the body’s immune system, including breakthroughs in the fight against tuberculosis, identifying the genes that cause the development of lung cancer and cystic fibrosis, and developing innovative ways to treat respiratory distress syndrome. To help advance this mission, ALA is inviting applications for its Innovation Award program. Through the program, grants of up to $75,000 a year for up to two years will be awarded in support of highly promising investigators with stellar track records of accomplishment and the potential to advance the field of lung disease science. Note: Applicants must have held a K or R type award within three years prior to applying for this award.
Due December 10, 2020. Med-RA deadline to receive draft documents: November 30.

Misophonia Research<https://urldefense.com/v3/__https://milkeninstitute.org/sites/default/files/2020-10/v22021*20Misophonia*20Research*20Fund*20RFP.pdf__;JSUlJQ!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmrIx8vxU$ >
Proposals must address one or more of the following three broad areas in human, animal, or relevant research models: 1) research focused on characterizing misophonia, including exploring its underlying mechanisms, expression, natural history, and/or development; 2) development of diagnostic tools to facilitate rapid, physiologically-relevant assessment; 3) clinical and/or model studies of specific interventions, including studies investigating comparative effectiveness, novel treatments, and controlled trials of promising treatments
The program supports two-year projects led by either faculty members or postdocs with annual budgets of up to $200,000.
Letter of intent due December 11, 2020. Med-RA deadline to receive draft documents: November 30.

Treatments for Lewy Body Dementias–Exploratory Clinical Trial (U01 Clinical Trial Required)<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-008.html__;!!PhOWcWs!igenTu2Mfk8DqrwmV6SHXub15u-mLVVqCe1U8-adHEvRv0_zAKXRZkeyDlTwuOCdphMt1Fb3BQvmotL4bqE$ >
This Funding Opportunity Announcement invites applications from investigators seeking to conduct exploratory clinical trials designed to test new treatments for patients with Lewy Body Dementia (LBD). Applicants may propose to conduct either Phase I or Phase II clinical trials depending on the developmental stage of the potential therapeutic, but all trials must include patients with LBD. Proposed therapies may include novel medications or devices, or existing treatments that are potentially beneficial but not currently approved for use in patients with LBD. Treatments intended to prevent or delay disease progression in LBD patients, as well as therapies to alleviate existing motor or non-motor clinical symptoms, are of interest.
Due March 2, 2020. Med-RA deadline to receive draft documents: February 17.

To search for additional funding opportunities, please visit CoM’s unofficial funding opportunities blog<https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=>.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.fsu.edu/pipermail/com_funding_opportunities/attachments/20201104/02109347/attachment.html>